Ob.Gyn. NewsESMO gets creative with guidelines for breast cancer care in the COVID-19 eraApril 28, 2020Breast CancerCOVID-19 Updates
Ob.Gyn. News‘Eye-opening’: Cognitive decline with endocrine therapy for breast cancerApril 23, 2020Breast Cancer
Ob.Gyn. NewsFDA approves first new breast cancer drug with international groupApril 20, 2020Breast Cancer
Ob.Gyn. NewsBreast-conserving surgery deemed okay in high-risk hereditary breast cancersApril 15, 2020Breast Cancer
Ob.Gyn. NewsWhen to treat, delay, or omit breast cancer therapy in the face of COVID-19April 10, 2020Breast CancerCOVID-19 Updates
Ob.Gyn. NewsHome-based chemo skyrockets at one U.S. centerApril 10, 2020COVID-19 UpdatesBreast CancerGynecologic Cancer
Ob.Gyn. News‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020COVID-19 UpdatesBreast CancerGynecologic CancerPractice Management
Ob.Gyn. NewsAdvice from the front lines: How cancer centers can cope with COVID-19April 2, 2020COVID-19 UpdatesBreast CancerGynecologic CancerPractice ManagementPreventive CareSurgery
Ob.Gyn. NewsNo staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerGynecologic CancerPractice ManagementPreventive CareSurgery
Ob.Gyn. NewsCLEOPATRA: Pertuzumab has long-term benefit in HER2+ breast cancerMarch 27, 2020Breast Cancer
